INS and metabolic dysfunction-associated steatohepatitis: Insulin signaling regulates glucose uptake, lipid biosynthesis and cellular growth in insulin sensitive tissues, and dysfunction of this pathway drives the development of type 2 diabetes, NASH, atherosclerosis and obesity.